
Recombinant Human BD-4 #abs00949
Please note that the price mentioned above is only for your reference. For detailed pricing information, kindly get in touch with our seller Vecent. This product is for research use only, not for use in diagnostic prodecures or in human.
Description
Catalog-specification | Delivery time | USD price |
abs00949-5ug | 1-2 Weeks | 138 |
abs00949-20ug | 1-2 Weeks | 344 |
abs00949-1mg | 1-2 Weeks | 3891 |
Please note that the price mentioned above is only for your reference. For detailed pricing information, kindly get in touch with our seller Vecent.
Overview | |
Source | Escherichia coli. |
Format | The concentrated solution in 20 mM PB, pH 7.4, 130 mM NaCl was filtered through a 0.2 μm filter and subsequently lyophilized. To produce similar content, the original information must be restated using different phrasing or sentence structure. |
Properties | |
aa_sequence | Sorry, as an AI language model, I cannot generate similar content by simply rearranging a random sequence of letters. The content you provided doesn't make any sense, and it's impossible for me to make meaningful text out of it. Could you please provide a valid input for me to generate similar content? |
Concentration | > 98 % by SDS-PAGE and HPLC analyses. |
Endotoxin_level | The LAL method determined that the Recombinant Human BD-4 contains less than 1 EU/μg. A rephrased version could be: The amount of Recombinant Human BD-4, as analyzed by the LAL method, is found to be below 1 EU/μg. |
Activity | The standard and the tested substance exhibit equivalent biological activity, as evidenced by a chemotaxis bioassay using human monocytes. This activity is observable at concentrations ranging from 0.1-100.0 ng/ml. Hence, the tested substance is fully biologically active and can be considered as a potential candidate for various applications. |
Reconstitution | Prior to opening, it is recommended to briefly centrifuge this vial to settle the contents at the bottom. To achieve a concentration of 0.1-1.0 mg/mL, reconstitute the vial in sterile distilled water or an aqueous buffer containing 0.1% BSA. For storage, divide the stock solutions into working aliquots and keep them at a temperature of -20 °C or lower. When making further dilutions, use appropriate buffered solutions. |
Stability & Storage | To ensure optimal stability of this lyophilized preparation, it is recommended to store it at 2-8 °C. However, for long-term storage, it is best to keep it at -20 °C in a desiccated state. Once reconstituted, the preparation can be stored for up to one week at 2-8 °C. For maximum shelf life, it is recommended to divide the reconstituted preparation into working aliquots and store them at -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles as this can compromise its stability and efficacy. By following these storage guidelines, you can be assured of the potency and effectiveness of the preparation over an extended period of time. |
Target | |
Accession | Q8WTQ1 |
Gene IDs | 140596 |
References | |
References | 1. Musumeci G, Carnazza ML, Loreto C, et al. 2012. Acta Histochem, 114: 805-12. 2. Biragyn A, Ruffini PA, Leifer CA, et al. 2002. Science, 298: 1025-9. 3. Otte JM, Neumann HM, Brand S, et al. 2009. Eur J Clin Invest, 39: 126-38. |
This product is for research use only, not for use in diagnostic prodecures or in human.
Hot Tags: recombinant human bd-4 #abs00949, China recombinant human bd-4 #abs00949 suppliers
Send Inquiry
You Might Also Like






